Roswell Park Comprehensive Cancer Center is pleased to announce the establishment of a Distinguished Lecture Series, sponsored by Cancer Center Director, Dr. Candace Johnson.
Representatives from all research departments and divisions (clinical and basic) have identified top-level speakers known for their groundbreaking research in each of their fields, including many who are Directors of Cancer Centers in their own right. In addition to their giving a 50-minute lecture on their research aimed at audiences that include students, medical fellows, basic and clinical researchers, invited distinguished speakers will meet with students, fellows, and faculty members to learn about and discuss the exciting ongoing research projects at Roswell Park.
All upcoming lectures will be hosted at Roswell Park Comprehensive Cancer Center
Gaylord Cary Conference Room, Research Studies Center
665 Elm Street (at the corner of Carlton & Elm Streets)
Buffalo, NY, 14263.
For additional details, please contact Amy Troutman at 716-845-3851 or Amy.Troutman@RoswellPark.org.
Upcoming Lectures:
Thursday, October 31, 2024, 3 p.m.
Hosted by:
Andrew Hyland, PhD
Professor of Oncology
Chair, Department of Health Behavior
Division of Cancer Prevention and Population Sciences
Roswell Park Comprehensive Cancer Center
Maansi Bansal-Travers, PhD
Associate Professor of Oncology
Department of Health Behavior
Roswell Park Comprehensive Cancer Center
Wilson M. Compton, MD, MPE is Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health, where he has worked since 2002. Dr. Compton received his undergraduate education at Amherst College and medical education, including psychiatry training, at Washington University in St. Louis.
Over his career, Dr. Compton has authored over 250 publications and often speaks at high-impact venues. He was a member of DSM-5’s Revision Task Force and has led, for NIDA, development of the Population Assessment of Tobacco and Health Study, jointly sponsored by NIDA and the U.S. Food and Drug Administration (FDA), with 45,971 participants. Dr. Compton has received multiple awards, including FDA awards for collaboration in 2012, 2013 and 2017.
He is also a recipient of the Health and Human Services Secretary’s Awards for Meritorious Service in 2013 and Distinguished Service in 2015, 2018 2019, and most recently in 2024, for his work on the CMS-NIH-CDC-SAMHSA Opioid Policy Data Team.